Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Stock Information for Microbot Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.